Daniel O’Mahoney, PhD
Daniel O’Mahony is a Partner at Seroba Life Sciences venture capital fund and brings a wealth of experience from pharma and medtech industry in product development, clinical trials, product commercialisation, strategic planning, licensing, corporate venturing, technology commercialisation and venture capital investment. Daniel graduated with a Ph.D. from University College Cork, holds a business degree in technology management from the Smurfit Business School, University College Dublin and has held academic appointments in Ireland and USA. He currently sits on a number of boards including Carballo Group Limited, Perfuze and ATXA Therapeutics. He previously sat on the boards of PQ Bypass (acquired by Endologix), Novate Medical (acquired by BTG), Apica Cardiovascular (acquired by Thoratec), Covagen (acquired by Janssen), Atlantic Therapeutics (acquired by Caldera Medical inc), Stokes Bio (acquired by Life Technologies). Seroba is currently investing from its new fund, Fund IV with a focus in pharma /biotech and medtech investments.